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Figure 1
Linkage analysis of NK cell deficiency 
in humans. (A) Pedigrees of the two 
families. Generations are designated 
by Roman numerals I–IV. Patients with 
low counts of NK cells (P1.1, P1.2, P1.3, 
P1.4, P1.5, and P2.1) are represented by 
black symbols. The index case is indicat-
ed by an arrow. All other family members 
with normal NK cell counts are indicated 
by white symbols. A star indicates that 
the individual has been genotyped for all 
the microsatellites considered, whereas 
a circle indicates that genotyping has 
been carried out only for the 8p12–q12.2 
region. Absolute numbers (per mm3 of 
whole blood) and percentages (% of 
lymphocytes) of NK cells are indicated 
for each individual, for the first whole-
blood sample analyzed. (B) Multipoint 
linkage analysis of chromosome region 
8p12–q12.2 by homozygosity mapping. 
Microsatellite positions are indicated in 
cM. In total, 9 microsatellites were geno-
typed between D8S1821 and D8S1745. 
The gray line represents kindred A lod 
score, and the black line represents the 
combined lod score for kindreds A and B. 
(C) Schematic representation of the 
candidate region (8p11.23–q11.21). 
The region of interest was delineated 
between microsatellites D8S1821 and 
D8S1745. This region is 12 Mb long and 
contains 1 microRNA and 45 predicted 
protein-coding genes.
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The MCM4 mutation is not associated with a loss of expression. (A) Automated sequencing profiles showing the homozygous MCM4 
c.70_71insG mutation in genomic DNA extracted from EBV-B cells of a patient and a WT control. Bottom: Schematic diagram of the structure of 
the MCM4 gene, consisting of 16 or 17 exons (Roman numerals), indicating the position of the mutation, which affects the acceptor splice site of 
intron 1. (B) Sequencing profile of a patient and a control indicating the insertion of a G nucleotide in the cDNA extracted from EBV-B cells. The 
position of the mutation is shown on a diagram of the MCM4 gene. The dotted lines represent the two mRNA transcripts produced from MCM4. 
The homozygous mutation leads to the insertion of an additional nucleotide between exons 1 and 2. (C) A schematic diagram of the MCM4 pro-
tein, which has an N-terminal serine/threonine-rich domain (dark gray) and a conserved MCM domain (light gray) including an ATP-binding site 
(black) toward its C terminus. The homozygous mutation results in a frameshift, creating a premature stop codon in exon 2. Bottom: Western blot 
analysis of MCM4 on total protein extracts from primary fibroblasts and SV40 fibroblasts from P1.3 and P2.1 and EBV-B cells from P1.2, controls. 
A polyclonal MCM4 antibody was used. (D) Complementation, by lentiviral particles, of SV40 fibroblasts from the controls and patients, with an 
empty pTRIP vector, an MCM4 WT vector, and the MCM4 c.71-2A→G mutation (MCM4 MUT). MCM4 was detected with a polyclonal antibody. 
The empty vector and non-transfected cells were used as a negative transfection control. In C and D, GAPDH was used as a loading control.
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The MCM4 mutation causes genomic instability, which is comple-



















Characterization of the MCM4 isoforms detected in the cells of the patient tested. Reinitiation of MCM4 protein translation. (A) Schematic 
diagram of the two potential reinitiation sites after the premature STOP codon and the corresponding isoforms of MCM4. Two ATG codons, at 
positions 51 and 75, are in the same open reading frame as the premature stop codon, leading to the production of two new isoforms, of 813 
and 789 amino acids, respectively. The 5′ part of the MCM4 sequence is enlarged (×6) and shown at greater magnification than the 3′ part of 
the MCM4 sequence (×1). The two variants of MCM4 mRNA from the NCBI database are shown (NM 005914.3 and NM 182746.2). (B) MCM4 
protein levels, in HEK293T cells, following transient transfection with a C-terminal Flag-tagged pCMV6 empty vector or pCMV6 MCM4 WT, 
pCMV6 MCM4 MUT, pCMV6 MCM4 MUT-ATG1, pCMV6 MCM4 MUT-ATG2, pCMV6 MCM4 MUT-ATG1+2, pCMV6 MCM4-ATG1, and pCMV6 
MCM4-ATG1+2 vectors, were assessed by Western blotting of total protein extracts from each transfection with antibodies against Flag and 
against the MCM4 protein. Total protein extracts from non-transfected control SV40 fibroblast (SV40-Fib) cell lines from a control and patient 
P2.1 were used as a positive control. An antibody against β-actin was used as a loading control.
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Functionality of the MCM4 isoforms detected in the cells of the patient. 
(A) The Triton X–extractable fraction from patient and control SV40 
fibroblasts was subjected to immunoprecipitation with a monoclonal 
antibody against MCM2. Protein extracts and immunoprecipitates were 
analyzed by immunoblotting with antibodies against MCM4, MCM3, 
MCM5, and MCM6. MCM2 was used as a loading control. (B) The 
chromatin-bound fraction was subjected to immunoprecipitation with a 
monoclonal antibody against MCM2. This procedure was carried out 
on the DNase I–extracted fractions of both control cells and cells from 
the patient. Protein extracts and immunoprecipitates were analyzed 
by immunoblotting with antibodies against MCM4, MCM3, MCM5, and 
MCM6. MCM2 was used as a loading control. Immunoprecipitation 
with IgG was used as a negative control. (C) Representative flow 
cytometry plots of the cell cycle of SV40 fibroblasts from controls and 
patients. Control (left), P1.3 (middle), and P2.1 (right) cell cycles in 
the absence of treatment. Transformation of cells with SV40 T antigen 
causes increased ploidy of all cells (59). P1 corresponds to normal 
G1 phase, P2+P3+P4 correspond to normal S phase, P5 corresponds 
to normal G2 phase plus abnormal G1 or failed mitosis, P6+P7 corre-
spond to re-replication S phase, and P8 corresponds to 8C (P8) DNA 
content. Patients’ SV40 fibroblasts with or without 0.3 μM aphidicolin 
(Aph) treatment. (D) Representative chromosome spreads of chromo-
some breaks induced with or without aphidicolin. A WT metaphase 
chromosome without aberrations (left); a P1.3 metaphase with some 
aberrations indicated by blue arrowhead (middle); and a P1.3 meta-
phase after aphidicolin treatment, with chromosomal aberrations 
indicated by arrowheads (right). Blue arrowheads indicate chromatid 
breaks, and red arrowheads indicate chromosome exchanges. Bot-
tom: Chromosome breaks (mean) per metaphase in P1.3 and P2.1 
SV40 fibroblasts and in control SV40 fibroblasts. Complementation by 
lentiviral transduction with the WT MCM4 allele, the empty vector, or 
the c.70_71insG allele in P1.3 SV40 fibroblasts. Error bars indicate 
SEM. ***P < 0.0005, Student’s t test.
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Homozygous MCM4 mutation and specific NK CD56dim deficiency. (A) Quantitation, by flow cytometry, of peripheral total NK cells and of the 
CD56bright and CD56dim NK cell subsets in controls (n = 22), heterozygous subjects (n = 2), and homozygous patients (P1.1, P1.2, and P1.3). 
Horizontal bars represent medians. ***P < 0.0005, Student’s t test. Bottom: Representative flow cytometry plots of a homozygous WT sibling, 
a heterozygous sibling, and one patient. (B) PBMCs from 6 independent healthy controls and from one patient (P1.3) tested in 2 independent 
experiments were stained with CFSE and stimulated for 72 hours with various doses of IL-2. Apoptosis was assessed on NK subsets, by 7-AAD 
staining. Error bars indicate SD.
research article










































































































































































































ufacturer’s  instructions: MCM4 MUT  (Flag-CMV6 MCM4 with  the 
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